Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia:: lack of association with incidence, disease stage and progression-free survival

被引：13

作者：

Nueckel, H ^{[1
]}

Frey, UH

Sellmann, L

Bau, M

Duerig, J

Duehrsen, U

Siffert, W

机构：

[1] Univ Essen Gesamthsch, Fac Med, Dept Hematol, Essen, Germany

[2] Univ Essen Gesamthsch, Fac Med, Inst Pharmagenet, Essen, Germany

来源：

LEUKEMIA | 2006年 / 20卷 / 04期

关键词：

D O I：

10.1038/sj.leu.2404126

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：724 / 724

页数：1

共 4 条

[1] Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses [J].

Kitada, S ;

Andersen, J ;

Akar, S ;

Zapata, JM ;

Takayama, S ;

Krajewski, S ;

Wang, HG ;

Zhang, X ;

Bullrich, F ;

Croce, CM ;

Rai, K ;

Hines, J ;

Reed, JC .

BLOOD, 1998, 91 (09) :3379-3389

[2]

SCHENA M, 1992, BLOOD, V79, P2981

[3]

SKOGSBERG A, 2005, LEUKEMIA

[4] Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic leukemia once treatment is initiated [J].

Starczynski, J ;

Pepper, C ;

Pratt, G ;

Hooper, L ;

Thomas, A ;

Milligan, D ;

Bentley, P ;

Fegan, C .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1514-1521

← 1 →